Scientists decode secrets of a very common virus that can cause cancer

	Tweet

About 90 percent of people are infected at some time in their lives with Epstein-Barr virus (EBV), usually with no ill effects. But individuals with compromised immune systems, such as people with organ transplants or HIV infection, have a greater risk of cancer occurring because of this virus.

Scientists at the Duke Cancer Institute have discovered a pathway that infected cells use to root out EBV infections, a finding that has implications for understanding the human response to cancer-causing viruses in general.

“Using cell culture studies, we have uncovered a major pathway that the infected host cell activates to prevent an oncogenic virus from causing cancer,” said senior author Micah Luftig, Ph.D., Assistant Professor of Molecular Genetics and Microbiology. “We proposed that the cell was sensing that the virus is trying to take over. When this oncogenic stress response is activated, it keeps the virus in check, and now we know why.”

The Luftig group also learned how the Epstein-Barr virus overcomes the cell’s response. “The findings may eventually yield therapies to benefit people who don’t have good immune systems and who need protection from a threatening EBV infection,” Luftig said.

This work appears in the Dec. 15 online issue of Cell Host and Microbe.

Very early in many people’s lives, there is a huge expansion of immune system B cells infected with EBV. But thanks to the oncogenic stress response and a strong immune system, the majority of these infected cells are killed off and the person remains healthy. Luftig and his group, including lead authors Pavel Nikitin and Chris Yan, found two enzymes, called kinases, which were critical in mediating this oncogenic stress response and preventing unchecked B-cell cell growth, called immortalization.

When the scientists blocked the ATM and Chk2 kinases, unchecked growth resulted in 10 times more infected cells. This burgeoning cell growth is related to several types of cancer, including post-transplant lymphoproliferative disorder, in which a transplant patient gets a form of lymphoma because of B-cell proliferation, and HIV-associated B-cell lymphomas among others.

“This finding can be extended to the general case of any oncogene being activated that might start the process of tumor formation,” Luftig said. “About 20 percent of all human cancers are caused by infectious agents, where about 80 percent of these infections are viral.” Another example of a viral infection leading to cancer is the human papillomavirus, implicated in cervical cancer.

Epstein-Barr virus infection can mean different courses for different people. In children 4-5 years old, a first infection with the virus may cause a mild illness, but if this primary infection happens during adolescence, the person may suffer a case of mononucleosis with heavy fatigue and other symptoms. In immune-compromised people, the virus can do much worse damage and cause forms of lymphoma.

###
Other authors include Eleonora Forte, Alessio Bocedi, Jay Tourigny, Katherine Hu, Jing Guo, David Tainter and Elena Rusyn of the Duke Department of Molecular Genetics and Microbiology, and Amee Patel, Sandeep Dave and William Kim of the Duke Institute for Genome Sciences & Policy as well as Rob White and Martin Allday of the Imperial College London.

For more information about Luftig lab’s studies: http://mgm.duke.edu/faculty/luftig/index.htm

Funding for this study came from the American Cancer Society, the National Cancer Institute, the Duke Center for AIDS Research, the Duke Comprehensive Cancer Center, and Golfers Against Cancer.

###

Contact: Mary Jane Gore

919-660-1309
Duke University Medical Center

RELATED STORIES:
Biomedical engineers use electric pulses to destroy cancer cells   Simple test could hold key to early diagnosis of cancers   Cancer drug Glivec may harm bones   Vanderbilt First to Use Specialized PET/CT Scan to Uncover Cancerous Tumors   Researchers Identify Role of Gene in Tumor Development   Researchers Identify a Weak Link in Cancer Cell Armor   Custom-made cancer cell attacks   Harmless soil-dwelling bacteria successfully kill cancer   Antibody signal may redirect inflammation to fuel cancer   The future of personalized cancer treatment: An entirely new direction for RNAi delivery   The solitary pulmonary nodule - malignant or benign?   Cell-Death Receptor Links Cancer Susceptibility and Inflammation   New DNA technique leads to a breakthrough in child cancer research   Cancer rates in U.S. keep falling: American Cancer Society   Fruit research yields way to curb cancer   Research Reveals What Drives Lung Cancer’s Spread   Antioxidant found in many foods and red wine is potent and selective killer of leukemia cells   How cancer cells loose their (Circadian) rhythm   Cancer Cells Need Normal, Non-mutated Genes to Survive   High iron and cholesterol equals high cancer risk   Compound that blocks sugar pathway slows cancer cell growth   Gene Therapy, Cancer-Killing Viruses and New Drugs Highlight Novel Approaches to Cancer Treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]